Home Latest News Over 60% of Mental Health Drugs in India are “Unapproved” and Lack Proven Benefits: New Study Finds
Latest News

Over 60% of Mental Health Drugs in India are “Unapproved” and Lack Proven Benefits: New Study Finds

Share
Share

A recent study has highlighted a concerning issue in India’s healthcare system. Over 60% of fixed-dose combination (FDC) drugs used to treat mental health disorders in India are “unapproved” and lack proven therapeutic value, according to a report by The Print. This alarming finding comes as the nation’s top drug regulatory body intensifies its crackdown on these unapproved drugs.

Findings from the Study

The study, published this month in the Journal of Pharmaceutical Policy and Practice, involved researchers from the UK, India, and Qatar. Their research found that unapproved FDCs made up 60.3% of psychotropic FDC sales in 2020. While this is a slight decrease from 69.3% in 2008, it still represents a significant issue in the Indian pharmaceutical market.

Fixed-dose combination drugs are blends of two or more drugs in a single pharmaceutical form, such as a capsule or tablet. In India, many of these drugs are available without approval from the Central Drugs Standard Control Organisation (CDSCO). Instead, they are approved for manufacture by state authorities, often without sufficient proof of their safety and efficacy.

Concerns Over Unapproved FDCs

The study raised serious concerns about the widespread marketing of psychotropic FDCs in India. Despite their exclusion from Indian clinical guidelines, minimal evidence supporting their benefits, and concerns about potential harm, these drugs continue to be heavily promoted in the country. Moreover, their usage is limited in other markets, making their prevalence in India particularly concerning.

The persistence of unapproved FDC drugs in the market is troubling, as these drugs have not undergone rigorous evaluations to confirm their safety and effectiveness. The researchers emphasized that these drugs could pose significant risks to patients who rely on them for mental health treatment.

Expert Opinion on the Issue

Ashna Mehta, a health economist and co-author of the study, pointed out that the issue of unapproved FDCs in India is not new. “The issue of unapproved FDCs in India is well-known,” she said. Despite various attempts by the drug regulator to eliminate these drugs from the market, they continue to be widely available. This ongoing challenge suggests that more robust measures are needed to protect public health.

Government Crackdown on FDC Drugs

In a related development, the Indian government recently imposed a ban on 156 additional fixed-dose combination (FDC) drugs, citing potential risks to human health. This action marks the most significant crackdown on FDC drugs since 2018 when 344 such combinations were banned for being “irrational.”

The recent ban, announced on August 12, includes several widely available antibiotics, as well as drugs for treating fever, allergies, colds, skin disorders, and pain. The ban also targets combinations of commonly used active pharmaceutical ingredients (APIs) with herbs like ginkgo biloba and formulations that mix vitamins and enzymes.

Additionally, the government prohibited multi-enzyme complexes containing up to 12-15 enzymes and over 20 formulations containing naphazoline, a decongestant commonly found in eye drops.

This ban is a critical step in addressing the widespread issue of unapproved FDC drugs in India, but it also underscores the need for ongoing vigilance and enforcement to protect the health of millions of Indians.

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss

Bundibugyo Ebola virus
International NewsVirus & DiseaseWHO

From Fever To Organ Failure: How The Bundibugyo Ebola Virus Affects The Body

The Bundibugyo Ebola virus outbreak has raised fresh global health concerns as infections continue to spread across parts of Central and East Africa....

WHO
Health TipsInternational NewsLatest NewsLifestyle & WellnessWHO

WHO Issues First Type 1 Diabetes Guidelines for Adults: 7 Things Patients Need to Know

More than 100 years after the discovery of insulin, millions of people living with type 1 diabetes continue to face challenges in accessing...

Breast Cancer
Health NewsOncology

Mammogram vs Ultrasound vs MRI: Which Breast Cancer Screening Test Is Right for You?

Breast cancer is one of the most common cancers affecting women worldwide, and early detection plays an important role in improving treatment outcomes....

Always Tired? It Could Be Anaemia!
Diet & NutritionHealth NewsHealth TipsLifestyleLifestyle & WellnessWellness

Anaemia in India: Why Iron Deficiency Remains a Concern and 7 Signs You Should Not Ignore

Feeling tired all the time, experiencing frequent dizziness or getting breathless after climbing a few stairs? While these symptoms are often dismissed as...

N95 Mask
Health TipsLatest NewsLifestyle & WellnessWellness

Does Wearing an N95 Mask Protect You From PM2.5 Pollution? Doctors Explain How To Choose And Wear It Correctly

As air pollution continues to affect several Indian cities during winter, wearing a mask has become an important precaution for people stepping outdoors....

Section title

Related Articles
Latest NewsWHO

WHO Releases First-Ever Guidelines For Type 1 Diabetes In Adults: 5 Key Recommendations Explained

The World Health Organization (WHO) has issued its first-ever guidelines for the...

Health NewsLatest NewsLifestyle

7 Simple Ways to Protect Yourself from Air Pollution

Air pollution has become a major health concern today. Dust from construction...